Evaluating the ability of different chaperones in improving soluble expression of a triple-mutated human interferon gamma in Escherichia coli
Journal of Bioscience and Bioengineering · 2024
DOI: 10.1016/j.jbiosc.2024.06.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Bioscience and Bioengineering, 2024. Verfasst von Umpa Yasamut und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Immunology, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailan…. Hauptthemen laut MEDLINE: Escherichia coli, Interferon-gamma, Molecular Chaperones, Solubility. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: Chiang Mai University.
Abstract (Originalsprache)
Human interferon gamma (hIFN-γ) plays a pivotal role as a soluble cytokine with diverse functions in both innate and adaptive immunity. In a previous investigation, we pinpointed three critical amino acid residues, i.e., threonine (T) 27, phenylalanine (F) 29, and leucine (L) 30, on the IFN-γ structure, which are integral to the epitope recognized by anti-IFN-γ autoantibodies. It is crucial to impede the interaction between this epitope and autoantibodies for effective therapy in adult-onset immunodeficiency (AOID). However, the challenge arises from the diminished solubility of the T27AF29L30A mutant in Escherichia coli BL21(DE3). This study delves into a targeted strategy aimed at improving the soluble expression of IFN-γ T27AF29AL30A. This is achieved through the utilization of five chaperone plasmids: pG-KJE8, pKJE7, pGro7, pG-Tf2, and pTf16. These plasmids, encoding cytoplasmic chaperones, are co-expressed with the IFN-γ mutant in E. coli BL21(DE3), and we meticulously analyze the proteins in cell lysate and inclusion bodies using SDS-PAGE and Western blotting. Our findings reveal the remarkable efficacy of pG-KJE8, which houses cytoplasmic chaperones DnaK-DnaJ-GrpE and GroEL-GroES, in significantly enhancing the solubility of IFN-γ T27AF29AL30A. Importantly, this co-expression not only addresses solubility concerns but also preserves the functional dimerized structure, as confirmed by sandwich ELISA. This promising outcome signifies a significant step forward in developing biologic strategies for AOID.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Clinical Immunology, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand; Center of Biomolecular Therapy and Diagnostic, Faculty of Associate…
- Center of Biomolecular Therapy and Diagnostic, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand.
Förderung
- Chiang Mai University
Zitieren
APA
Yasamut, U., Thongheang, K., Weechan, A., Sornsuwan, K., Juntit, O. A., & Tayapiwatana, C. (2024). Evaluating the ability of different chaperones in improving soluble expression of a triple-mutated human interferon gamma in Escherichia coli. Journal of Bioscience and Bioengineering. https://doi.org/10.1016/j.jbiosc.2024.06.005
Vancouver
Yasamut U, Thongheang K, Weechan A, Sornsuwan K, Juntit OA, Tayapiwatana C. Evaluating the ability of different chaperones in improving soluble expression of a triple-mutated human interferon gamma in Escherichia coli. Journal of Bioscience and Bioengineering. 2024. doi:10.1016/j.jbiosc.2024.06.005
BibTeX
@article{Yasamut2024,
author = {Yasamut, Umpa and Thongheang, Kanyarat and Weechan, Anuwat and Sornsuwan, Kanokporn and Juntit, On-Anong and Tayapiwatana, Chatchai},
title = {Evaluating the ability of different chaperones in improving soluble expression of a triple-mutated human interferon gamma in Escherichia coli},
journal = {Journal of Bioscience and Bioengineering},
year = {2024},
doi = {10.1016/j.jbiosc.2024.06.005}
}
EUVIMED